Latest filing published 23 Jun 2026 for GeneDx Holdings Corp..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Joshua Ruch in GeneDx Holdings Corp., where the filings describe the role as board member. We count 31 filings; the first trade dates from 27 April 2022 and the latest from 18 June 2026.
Sales make up the whole of the open-market record (15 sales, €5.3M). Besides market trades, the filings include 6 share grants and 10 option exercises.
Most recently, on 23 June 2026, the filings show an option exercise in GeneDx Holdings Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations